How Does Forte Biosciences Inc (FBRX) Stock Rank on Wall Street Wednesday?

Analysts who follow Forte Biosciences Inc (FBRX) on average expect it to climb 652.98% over the next twelve months. Those same analysts give the stock an average rating of Hold. That average rating earns the stock an Analyst Ranking of 4, which means it ranks higher than 4 of stocks, based on data compiled by InvestorsObserver.

Wall Street analysts are rating FBRX a Hold today. Find out what this means to you and get the rest of the rankings on FBRX!

See Full FBRX Report

Why are Analyst Ratings Important?

You can learn a lot about a company from looking at it’s financial statements and comparing them to other companies. Analysts who cover an industry in depth can add even more to your research though. They typically follow a particular sector or industry very closely. They also pay attention to and ask questions on earnings conference calls and other events where they might learn information that does show up in the numbers. InvestorsObserver takes the average rating from these analysts, and then percentile ranks those averages. This lets you compare stocks in a much more granular way than just seeing the typical five-tiered rating system used on most of Wall Street.

What's Happening With Forte Biosciences Inc Stock Today?

Forte Biosciences Inc (FBRX) stock is down -5.91% while the S&P 500 is up 0.24% as of 11:37 AM on Wednesday, Sep 15. FBRX has fallen -$0.23 from the previous closing price of $3.86 on volume of 1,964,729 shares. Over the past year the S&P 500 is up 30.95% while FBRX has fallen -91.28%. FBRX lost -$1.61 per share the over the last 12 months. Click Here to get the full Stock Report for Forte Biosciences Inc stock.